Back
LENZ Therapeutics, Inc. 10K Form
Sell
27
LENZ
LENZ Therapeutics, Inc.
Last Price:
$9.69
Seasonality Move:
-3.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LENZ News And Ratings
See the #1 stock for the next 7 days that we like better than LENZ
LENZ Financial Statistics
Sales & Book Value
| Annual Sales: | $19.1M |
|---|---|
| Cash Flow: | $-33.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.07 |
| Price / Book: | 1.07 |
Profitability
| EPS (TTM): | -2.80260 |
|---|---|
| Net Income (TTM): | $-82.1M |
| Gross Margin: | $18.4M |
| Return on Equity: | -38% |
| Return on Assets: | -35.69% |
LENZ Therapeutics, Inc. Earnings Forecast
Key LENZ Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for LENZ is 96.31%.
-
The Selling, General & Administrative Expenses for LENZ have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 97.81% of Revenue.
-
The Net Earning history of LENZ is -430.25% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 1 years.
LENZ Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LENZ |
| Website: | lenz-tx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 14.23 |
| Quick Ratio: | 13.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LENZ Technical Analysis vs Fundamental Analysis
Sell
27
LENZ Therapeutics, Inc. (LENZ)
is a Sell
Is LENZ Therapeutics, Inc. a Buy or a Sell?
-
LENZ Therapeutics, Inc. stock is rated a SellThe current LENZ Therapeutics, Inc. [LENZ] share price is $9.67. The Score for LENZ is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.